Search
Displaying 391–400 of 849 results for “vision connection”
-
Research News
The five-year grant will advance the emerging treatments toward clinical trials
-
Beyond Labels: The Inspiring Journey of a Refsum Disease Advocate
Beacon StoriesAfter years of seeking answers, Alan Gunzburg was formally diagnosed with Refsum disease, a rare genetic disorder. Drawing on his unique journey, Alan sheds light on the obstacles he’s faced and how his experience motivated him to make a positive impact in the lives of others.
-
Eye on the Cure Podcast | Episode 46: Aaron Osborne, MD
Eye on the CureMay 19, 2023. Aaron Osborne, MD, chief medical officer and chief development officer at Nanoscope Therapeutics, talks about vision restoration in clinical trials of the company’s optogenetic therapy for people with advanced vision loss from retinitis pigmentosa and Stargardt disease.
-
Eric Pierce Receives Proctor Medal for Outstanding Achievements in Retinal Research
Research NewsDuring his Proctor Award Lecture, Dr. Pierce reviewed encouraging clinical trial results for Editas’ CRISPR/Cas9 treatment for people with LCA10
-
Foundation News
The May 11th gala will raise awareness and fund research leading to treatments and cures for blinding retinal diseases.
-
Blind Paralympian Reaching New Heights
Beacon StoriesIsaac Jean-Paul was diagnosed with X-linked juvenile retinoschisis (XLRS) at the age of two. Isaac was always set on being a professional athlete, and now he’s a Paralympian, winning bronze in the long jump in the 2020 Games and breaking the high jump world record three times.
-
Disease
Mutations in PRPH2 are a relatively common cause of several inherited retinal degenerations, including: retinitis pigmentosa (RP), pattern macular dystrophies (PMDs), cone-rod dystrophies (CRDs), and central areolar choroidal dystrophy (CACD).
-
Progress toward a stem cell–based therapy for blindness
In the PressA multi-institutional effort led by researchers at the School of Veterinary Medicine is taking steps to develop an effective technique to regenerate photoreceptors cells and restore sight in people with vision disorders.
-
Research News
The emerging therapy is designed to restore vision for people with advanced retinal degenerative diseases
-
Apellis’ Treatment for Advanced Dry AMD to Receive Priority Review from FDA
Research NewsThere are currently no FDA-approved therapies for geographic atrophy (GA), the advanced form of dry AMD.
%20(5).png)
